Crinetics Pharmaceuticals Inc is a pharmaceutical company specialising in the development of novel therapeutics for endocrine diseases and endocrine-related cancers. The company operates on a global scale, targeting markets that need breakthrough treatments for rare conditions.
Positioned in the biotechnology sector, Crinetics Pharmaceuticals Inc conducts research and development in new technologies for endocrine oncology such as acromegaly, diabetes and obesity. The company's development of therapeutics is based on a pipeline of oral nonpeptide new chemical entities that target a variety of endocrine diseases.
Add CRNX stock to your eToro virtual portfolio.